Monitor for further DOJ announcements or enforcement actions. The investigation creates overhang; any escalation could materially impact the stock.
How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 18 $16.42entry
- T+1 · 6mo ago −1.34%α −0.69% · $16.20
- T+5 · 6mo ago +32.52%α +30.90% · $21.76
- T+20 · 5mo ago +86.78%α +85.20% · $30.67
- T+60 · 3mo ago +115.10%α +110.25% · $35.32
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Claritev discloses an ongoing DOJ antitrust investigation via a Regulation FD response to a media report. The company received a grand jury subpoena in August 2024 and states it is not a target, but legal uncertainty persists.
Key Facts
- Article on May 14, 2026 alleged DOJ criminal antitrust probe into Claritev.
- Company confirms receiving a confidential grand jury subpoena in August 2024 from DOJ Antitrust Division.
- Investigation relates to health insurance; company states it is cooperating and has not been named a target.
- No financial details or guidance provided in the filing.
Financial Impact
Potential legal costs and penalties undetermined; materiality depends on DOJ findings.
Risk Factors
- DOJ could escalate probe leading to fines or operational restrictions.
- Negative publicity may affect client relationships and revenue.
- Potential for shareholder lawsuits if investigation reveals misconduct.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001793229-26-000052 |
| Document: 0001793229-26-000052-index-headers.html | 0001793229-26-000052 |
| Document: 0001793229-26-000052-index.html | 0001793229-26-000052 |
| Document: 0001793229-26-000052.txt | 0001793229-26-000052 |
Track record
21 reports on CTEV
6 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +61.54% at T+60 after the Feb 27, 2026 report. 6 of 7 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $25.63 Now $24.99 −2.48% settles Nov 17
- Nov 13, 20262d ago Insider Cluster Neutral 4/10 Entry $27.34 Now $24.99 −8.60% settles Nov 17
- Nov 12, 20263d ago Insider Cluster Neutral 4/10 Entry $27.37 Now $24.99 −8.70% due Nov 16
- Nov 12, 20263d ago 144 Neutral 2/10 Entry $27.37 Now $24.99 −8.70% due Nov 16
- Nov 12, 20264d ago Insider Buy Bullish 4/10 Entry $26.90 Now $24.99 −7.10% due Nov 16
- Nov 10, 20265d ago 144 Neutral 2/10 Entry $28.21 to $26.90 Now $24.99 −11.41% ▼ −4.64% −4.29% vs SPY
- Nov 9, 20267d ago Press Release Mixed 6/10 Entry $24.00 to $28.67 Now $24.99 +4.12% ▲ +19.46% +19.83% vs SPY
- Oct 27, 202620d ago Insider Buy Bullish 5/10 Entry $23.00 to $24.00 Now $24.99 +8.65% ▲ +4.35% +4.73% vs SPY
- Oct 19, 202628d ago 3 Neutral 2/10 Entry $22.39 to $23.00 Now $24.99 +11.61% ▲ +2.72% +2.20% vs SPY
- Oct 15, 20264w ago 8-K Neutral 2/10 Entry $23.86 to $22.12 Now $24.99 +4.74% ▼ −7.29% −6.19% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers